ECOR vs LEN · rev $25.2M vs rev $34.19B
Electrocore LLC (ECOR) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Electrocore LLC (ECOR) is a medical devices company listed on US.
LEN (LEN) common stock.
Latest reported ECOR revenue for 2024-12-31 was $25.2M. Net income was -$11.9M. Revenue was up 57.1% from 2023-12-31 to 2024-12-31. ECOR currently screens at market cap $45.3M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
ECOR currently screens at market cap $45.3M. LEN currently screens at market cap $0.
Not investment advice. Open the ECOR and LEN stock pages for the full models.
Not investment advice.